Stock screener

BVS

Conviction 82HealthcareScan · Thu, Sep 24, 2026

Bioventus Inc. (BVS) closed at $13.53 (-0.62%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 95, -11.4% from its 52-week high, +87.6% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

BVS$13.53-0.62%
ResistanceSupportVol 14
63 bars
Vol MA14 480.71K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Bioventus Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.bioventus.com ↗
Price13.53
Change-0.62%
Gap-0.07%
Rel volume1.08×
Avg volume505.27K
Avg $ vol6.84M
SMA 2013.51
SMA 5013.44
SMA 20010.09
Price vs 50+0.63%
Price vs 200+34.04%
MA stackbullish
50/200 cross—
Supertrendup · 12.49
RSI (14)51
MACD hist-0.01
MACD cross—
Stoch %K / %D60 / 60
ADX (14)17
+DI / −DI21 / 21
RSI divergence—
MACD divergence—
ATR %3.82%
ADR %3.40%
52w high15.26
52w low6.51
From 52w high-11.37%
Above 52w low+107.76%
New 52w highNo
SqueezeOff
Bollinger width13.71%
%B0.51
Donchian pos54.86%
Donchian high14.50
Donchian low12.34
AVWAP (52w high)13.89
vs AVWAP high-2.66%
AVWAP (52w low)10.18
vs AVWAP low+32.85%
OBV trendFlat
Chaikin MF (20)0.16
Today vs 20d1.08×
Avg vol (14d)480.71K
Avg vol (20d)505.27K
Avg $ vol (20d)6.84M
Market cap932.07M
RS Rating95 / 99
RS 3m (vs SPY)+34.51%
RS 6m (vs SPY)+30.84%
RS line new highNo
Trend template8/8
Technical rank82.3
1 week+7.09%
1 month-3.94%
3 months+39.00%
6 months+47.65%
1 year+95.45%
YTD+87.59%
P/E41.00
P/B4.08
P/S1.64
P/FCF12.93
EPS0.3300
Div yield—
ROE9.96%
ROA3.38%
Debt/Eq1.09
Current1.69
EV/EBITDA11.40
Gross margin68.33%
Net margin4.00%
Rev growth-0.91%
EPS growth162.93%
Price target17.50
Target upside29.39%
Analyst ratingBuy
Institutional85.13%
Ent. value1.15B
Revenue153.21M
Net income33.44M
Gross profit105.67M
Free cash flow72.11M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out67.75M
Employees940
ListedThu, Feb 11, 2021
Free float38.83M
Float %58.0%
Short interest2.58M
Days to cover4.7d
Short volume62.4%
Squeeze score53 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.22 vs $0.22
Last surprise0.0% beat
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank82.3 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.41
Support12.51
Days since event—
Candle confirm—

Financials as of Sat, Jun 27, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BVS

All disclosures →
No recent disclosed trades by Congress in BVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BVS

InsiderSideShares
STALNECKER SUSAN M
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
McMurry-Heath Michelle
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
SUTTER MARTIN P
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Bartholdson John A.
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Cowdy Philip G.
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Ladone Mary Kay
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
HAWKINS WILLIAM A
Director · Restricted Stock Units · 2026-06-03
Grant30.99K
NOHRA GUY P
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Beyer Pat
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
NEELS GUIDO J
Director · Restricted Stock Units · 2026-06-03
Grant25.15K

SEC filings

EDGAR filings in BVS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.